Currently, there is no simple way to determine whether people will respond well, to a medication since pharmaceutical companies are limited to developing drugs using a "one size fits all" system. However not all patients respond well to drugs and many of them experience adverse drug reactions (ADR) and even deaths. Pharmacogenomics can solve the problem of ADRs by helping to make drugs targeted to patient's genes. In this way personalized medicine can improve health and save lives of people around the world. Pharmacogenomics has many applications in illnesses like cancer, cardiovascular disorders, depression, bipolar disorder, HIV, tuberculosis, asthma, and diabetes. FDA(US) and EMEA(EU) have started initiatives and published guidelines the last ten and more years to enhance personalized medicine. There are a lot of financial and ethical issues in industry that still need to be addressed to find the optimum pathway for personalized medicine globally.Why Should You Attend: This webinar will provide the new and expected regulations/ technologies and discuss their effects on the use of pharmacogenomics in industry. We will explain what the policies are, predict coming regulations and discuss how industry will be affected. We will explore the personalized medicine landscape in US, EU and globally.NetZealous LLC,DBA GlobalCompliancePanel 161 Mission Falls Lane,Suite 216, Fremont, CA 94539, USAUSA Phone:800-447-9407Fax: 302-288-6884